Pfizer Says Covid-19 Vaccine Effective For Kids Ages 5-11
On Monday, Pfizer announced that its Covid-19 vaccine is safe and effective for children aged 5-11 and that it will seek US authorization for this age group before the end of the month.
Pfizer tested smaller doses in the young children, a third of what's normally given to adults and teens. The trials proved to be effective with the young children developing antibodies against Covid-19 and having minimal side effects.
The findings set the stage for a potential vaccine rollout for young children in the next few months.
This is particularly significant as there has been a surge of new cases in children with the return to school and the spread of the Delta variant.
Photo Source: US DOD